4.6 Article

classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes

期刊

BMC BIOINFORMATICS
卷 23, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12859-022-04641-x

关键词

Colorectal Shiny CMS CRIS Immune; Cancer Subtype; Functional Annotation; Gene expression; Shiny application

资金

  1. DfE
  2. CRUK [C11884/A24367]
  3. HDR-UK grant [JHR1157100/1230]

向作者/读者索取更多资源

classifieR is an easy-to-use web application based on R-Shiny, designed to facilitate flexible and rapid single sample annotation of transcriptional profiles from cancer patient samples in laboratories. It provides information on the molecular makeup of samples, as well as analysis of prognosis, druggability, and discovery of new information.
Background: Transcriptionally informed predictions are increasingly important for sub-typing cancer patients, understanding underlying biology and to inform novel treatment strategies. For instance, colorectal cancers (CRCs) can be classified into four CRC consensus molecular subgroups (CMS) or five intrinsic (CRIS) sub-types that have prognostic and predictive value. Breast cancer (BRCA) has five PAM50 molecular subgroups with similar value, and the OncotypeDX test provides transcriptomic based clinically actionable treatment-risk stratification. However, assigning samples to these subtypes and other transcriptionally inferred predictions is time consuming and requires significant bioinformatics experience. There is no universal method of using data from diverse assay/sequencing platforms to provide subgroup classification using the established classifier sets of genes (CMS, CRIS, PAM50, OncotypeDX), nor one which in provides additional useful functional annotations such as cellular composition, single-sample Gene Set Enrichment Analysis, or prediction of transcription factor activity. Results: To address this bottleneck, we developed classifieR, an easy-to-use R-Shiny based web application that supports flexible rapid single sample annotation of transcriptional profiles derived from cancer patient samples form diverse platforms. We demonstrate the utility of the classifieR framework to applications focused on the analysis of transcriptional profiles from colorectal (classifieRc) and breast (classifieRb). Samples are annotated with disease relevant transcriptional subgroups (CMS/CRIS sub-types in classifieRc and PAM50/inferred OncotypeDX in classifieRb), estimation of cellular composition using MCP-counter and xCell, single-sample Gene Set Enrichment Analysis (ssGSEA) and transcription factor activity predictions with Discriminant Regu-Ion Expression Analysis (DoRothEA). Conclusions: classifieR provides a framework which enables labs without access to a dedicated bioinformation can get information on the molecular makeup of their samples, providing an insight into patient prognosis, druggability and also as a tool for analysis and discovery. Applications are hosted online at https://generatr.qub.ac.uk/app/classifieRc and https://generatrqub.ac.uk/app/classifieRb after signing up for an account on https://generatr.qub.ac.uk

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据